ViaNautis Appoints Ray Jupp as Chief Scientific Officer ViaNautis Appoints Ray Jupp as Chief Scientific Officer Cambridge, UK 21 October – ViaNautis Bio (“ViaNautis” or the “Company”), a groundbreaking biotechnology company at the forefront of genetic...

ViaNautis Bio appoints Dr Adi Hoess as Chief Executive Officer ViaNautis Bio appoints Dr Adi Hoess as Chief Executive Officer Cambridge UK, 18 October 2024 – ViaNautis Bio (“ViaNautis” or the “Company”), a groundbreaking nanomedicine company at the forefront...

ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors Co-Founder of Spark Therapeutics with over 20 years of industry experience to support ViaNautis Bio in its next...

ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors Co-Founder of Spark Therapeutics with over 20 years of industry experience to support ViaNautis Bio in its next...

ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicines ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicines ViaNautis’s proprietary drug delivery platform polyNaut® is designed to deliver...